Home > Journals > Minerva Pneumologica > Past Issues > Minerva Pneumologica 2011 June;50(2) > Minerva Pneumologica 2011 June;50(2):155-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PNEUMOLOGICA

A Journal on Diseases of the Respiratory System


Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index


eTOC

 

CASE REPORT  


Minerva Pneumologica 2011 June;50(2):155-8

language: English

Severe out-of-proportion pulmonary hypertension in adult COPD patient and therapy with bosentan

Battaglieri M. 1, Cantoni A. 2

1 Cardiorespiratory Section, Geriatric Department, Istituto Pio Albergo Trivulzio, Milan, Italy
2 Geriatrics, Istituto Pio Albergo Trivulzio, Milan, Italy


PDF  


Bosentan is a dual endothelin receptor antagonist, indicated for the treatment of pulmonary arterial hypertension (PAH). This paper presents our experience with bosentan therapy in a chronic obstructive pulmonary disease patient with concomitant severe pulmonary hypertension. The therapy implemented led to a gradual reduction in pulmonary artery pressure values and an improvement in a 6-minute walk test. Good tolerance and a safety profile in line with controlled clinical studies were also observed.

top of page

Publication History

Cite this article as

Corresponding author e-mail